Neurocrine Biosciences, Inc. (NBIX)

4 CNS Drug Stocks Worth Watching This World Mental Health Day

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Borg Warner, Boyd Gaming, JetBlue, Lattice Semiconductor, Lockheed Martin, Nike, Northrop Grumman, Procter & Gamble, SPX Technologies, and More

Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference

Neurocrine Biosciences Appoints Eiry W. Roberts, M.D.

Neurocrine Maps AI, China and Pipeline Strategy as INGREZZA Faces 2029 Price Hit

Integrated Wealth Concepts LLC Sells 5,703 Shares of Neurocrine Biosciences, Inc. $NBIX

Corient Private Wealth LP Buys 9,645 Shares of Neurocrine Biosciences, Inc. $NBIX

Neurocrine Biosciences, Inc. (NBIX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Engineers Gate Manager LP Increases Holdings in Neurocrine Biosciences, Inc. $NBIX

Amundi Has $37.16 Million Position in Neurocrine Biosciences, Inc. $NBIX

Neurocrine Biosciences, Inc. (NBIX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

Neurocrine Biosciences, Inc. (NBIX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Continuum Advisory LLC

Neurocrine Biosciences to Present at Upcoming Investor Conferences in September

Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?

NBIX vs. TEVA: Which Drugmaker Is the Better Investment?

B. Metzler seel. Sohn & Co. AG Acquires New Shares in Neurocrine Biosciences, Inc. $NBIX

Allworth Financial LP Invests $2.50 Million in Neurocrine Biosciences, Inc. $NBIX

Neurocrine Biosciences: 'House Full Of Options'

Neurocrine's Ingrezza Sales Keep Growing: Can the Momentum Last?